SCHEMBL20734344

SCHEMBL20734344

c1ccc(B2N(c3ccccc3)B(c3ccccc3)N(c3cccc(-n4c5ccccc5c5c4c4ccccc4n5-c4ccccc4)c3)B(c3ccccc3)N2c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ATM Q13315 1/20 0.44
MAPK8 P45983 2/20 0.38
MAPK9 P45984 1/20 0.38
PGR P06401 2/20 0.35
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 3/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
POLB P06746 1/20 0.34
BRCA1 P38398 1/20 0.34
IL1R1 P14778 1/20 0.33
FOLH1 Q04609 2/20 0.32
KDR P35968 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
MAPK1 P28482 2/20 0.32
CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20734253 0.89 L3MBTL1 (0.53) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL20734357 0.87 L3MBTL1 (0.50) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL20734385 0.86 L3MBTL1 (0.42) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL20734250 0.84 KDM4E (0.47) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL15144191 0.84 L3MBTL1 (0.61) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL20734430 0.82 L3MBTL1 (0.45) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL20734360 0.81 L3MBTL1 (0.55) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL20734359 0.81 L3MBTL1 (0.64) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL17689873 0.81 L3MBTL1 (0.69) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL15144210 0.79 L3MBTL1 (0.64) L3MBTL1KDM4EATMMAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190051829-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190051829-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ORC3, BMP2, PPIP5K2 L3MBTL1 3117/4885KDM4E 2721/4885ATM 4733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.